Publication | Open Access
Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma
126
Citations
19
References
2016
Year
Increased risk for cutaneous squamous cell carcinomas after vismodegib therapy highlights the importance of continued skin surveillance after initiation of this therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1